Frontlight ResearchEarly access
Trial site
Harbin Medical University Affiliated Cancer Hospital
- 7running trials
- 1closed trial
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Metastatic breast cancer2 trials
- Triple-negative breast cancer2 trials
- Colorectal cancer1 trial
- Gastric and oesophageal cancer1 trial
- Liver and biliary tract cancer1 trial
- Lung cancer1 trial
- Pancreatic cancer1 trial
- Phase
- Phase 24 trials
- Phase 1/23 trials
- Phase 31 trial
- Status
- Not yet recruiting4 trials
- Active, not recruiting2 trials
- Completed1 trial
- Recruiting1 trial
- Lead sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.2 trials
- Betta Pharmaceuticals Co., Ltd.1 trial
- CARsgen Therapeutics Co., Ltd.1 trial
- Huahui Health1 trial
- Shandong Suncadia Medicine Co., Ltd.1 trial
- and 2 more
Running trials
Recruiting
Not yet recruiting
Recruiting
Not yet recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CT041 Autologous CAR T-cell Injection
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Triple-negative breast cancer2 recruiting
- Liver and biliary tract cancer1 recruiting
- Lung cancer1 recruiting
- Metastatic breast cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026